Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Peptic Ulcer Drugs Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.
The peptic ulcer drugs market attained a value of USD 6.12 Billion in 2024. The market is further expected to grow in the forecast period of 2025-2034 at a CAGR of 3.80%, to reach USD 8.89 Billion by 2034. 
The report covers 8 major markets poised to witness significant peptic ulcer drugs market growth in upcoming years. It is divided into the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. North America dominates the market for peptic ulcer drugs which can be attributed to the rising cases of the disease, along with the growing healthcare expenditure in the region.
The surge in drug approvals by the health regulatory bodies is expected to further bolster the market growth. In October 2023, the United States Food and Drug Administration (FDA) approved reformulated vonoprazan tablets for Voquezna Triple Pak and Voquezna Dual Pak to treat Helicobacter pylori infection in adults. Developed by Phathom Pharmaceuticals, a United States-based biopharmaceutical company, these drugs combine antibiotics with vonoprazan, a novel potassium-competitive acid blocker. This new class of acid suppression therapy offers promising H. pylori eradication rates. The company plans to commercially launch it in December 2023 for H. pylori treatment.
The peptic ulcer drugs market share is also expected to experience a significant expansion due to increasing research and development activities backed by robust support from the government. Moreover, the growing geriatric population and advancement in the healthcare system will also boost the market growth.
Key Queries Solved in the Peptic Ulcer Drugs Market Report
- How is the market landscape expected to evolve in coming years?
- What are the major market trends influencing the market?
- What are the major drivers, opportunities, and restraints in the market?
- What will be the effect of each driver, challenge, and opportunity on the market?
- Which country is poised to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What factors contribute to the rising peptic ulcers market demand?
- What is the incidence and epidemiology of peptic ulcers?
- What are the different types of peptic ulcer drugs available in the market?
- What are the latest advancements in peptic ulcer drug research and development, including novel drug candidates and formulations?
- Which drugs are under clinical trials?
- What were the major drug approvals used to manage peptic ulcers during the historical period?
- Which major drug manufacturers are expected to lead the market?
- What are the key strategies adopted by leading pharmaceutical companies to gain market share?
- How are partnerships, collaborations, and mergers & acquisitions shaping the market dynamics of peptic ulcer drugs?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 400 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value (USD) in 2025 | $6.12 Billion |
| Forecasted Market Value (USD) by 2034 | $8.89 Billion |
| Compound Annual Growth Rate | 3.8% |
| Regions Covered | Global |
Peptic Ulcer Drugs Market: Competitor Landscape
- Orion Corporation
- Bausch Health Companies Inc
- CYTOKINETICS, Inc
- Aquestive Therapeutics, Inc
- Sanofi
- Covis Pharma
- Sun Pharmaceuticals Industries Ltd
- Mitsubishi Tanabe Pharma Corporation
- BrainStorm Cell Limited
- ViroMed Co., Ltd
- Ionis Pharmaceuticals
- Genervon Biopharmaceuticals, LLC
- Biogen
- Orphazyme A/S
- F. Hoffmann-La Roche Ltd
Peptic Ulcer Drugs Market Segmentation
Market Breakup by Product Type
- Proton Pump Inhibitor
- H2 Antagonist
- Antibiotics
- Antacids
- Ulcer Protective
Market Breakup by Disease Indication
- Gastritis
- Gastric Ulcer
- Duodenal Ulcer
- GERD
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
- Germany
- France
- Italy
- Spain
- United Kingdom
- Japan
- India
For more information about this report visit https://www.researchandmarkets.com/r/9cnwdn
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
